Treatment-Related Interstitial Lung Disease

Through the lens of multidisciplinary management in breast cancer, experts share practical insight on the identification and management of interstitial lung disease.

EP. 11: An Overview of Interstitial Lung Disease

September 24th 2021

Joyce A. O’Shaughnessy, MD, provides an overview of interstitial lung disease, considering both causes and possible risk factors.

EP. 12: Identifying ILD: Symptomology and Work-Up

September 24th 2021

Comprehensive insight on the symptomology of interstitial lung disease, followed by tools and methods that can aid in accurate diagnosis.

EP. 13: Identifying Risk Factors for Interstitial Lung Disease

October 1st 2021

A brief review of the full spectrum of risk factors that impact the likelihood of interstitial lung disease.

EP. 14: Monitoring Patients for Interstitial Lung Disease

October 1st 2021

Experts discuss the optimal monitoring of patients to identify interstitial lung disease early and how to intervene.

EP. 15: Approaching the Management of Interstitial Lung Disease

October 8th 2021

Experts consider the mainstays in ILD management and factors that may dictate one treatment strategy over another.

EP. 16: Managing ILD: Taking Therapeutic Class Into Account

October 8th 2021

Brief considerations for the impact an agent’s therapeutic class can have on how interstitial lung disease should be approached.

EP. 17: Optimizing the Management of ILD: Steroids, Therapy Cessation, and Dose Modification

October 15th 2021

A broad review of strategies to manage interstitial lung disease, including steroid use, therapy cessation/rechallenging, and dose reduction.

EP. 18: Role of Bronchoscopy in Identifying and Managing ILD

October 15th 2021

Charles A. Powell, MD, MBA, leads a discussion on bronchoscopy’s role in identifying interstitial lung disease.

EP. 19: Understanding the Risk-Benefit Comparison of Agents That May Cause ILD

October 22nd 2021

Key opinion leaders share risk-benefit considerations when utilizing therapies that may increase a patient’s risk of developing ILD.

EP. 20: Multidisciplinary Care in ILD Management: Role of a Pulmonologist

October 22nd 2021

Shared insight on the benefit of multidisciplinary care and the pulmonologist’s role in identifying and managing interstitial lung disease.